A consortium co-led by the University of Helsinki awarded 2 million euros for research of severe paediatric SIRS
The research can help improve the investigation of root causes, tailored treatments and prognosis of severe paediatric SIRS.
Researchers find that accessory subunit plays a key role in biological energy conversion by mitochondrial complex I
By combining the power of structural biology, biochemistry and multiscale molecular simulations, researchers from Germany and Finland found a...
Professor Emeritus Kari Alitalo receives honorary title of Academician of Science
Research Director, Professor Emeritus Kari Alitalo has been conferred the honorary title of Academician of Science.
Multi-species bacterial communities have the ability to bounce back from environmental disturbances
Perturbations in the environment are common, and bacterial communities consisting of several species seem to find their way around the crisis...
Juha Huiskonen appointed as Director of Institute of Biotechnology at the University of Helsinki
Huiskonen will assume the position in September and alongside his director duties continues structural biology research.
In the fast lane for drug discovery
To date, no specific vaccines or antiviral drugs have been developed for SARS-CoV-2. Drug discovery is hindered by the fact that viruses do not...
A drug lead molecule studied by Viikki Biochemists may help in the fight against COVID-19
Since 2014, Tenure Track Group Leader Ville Paavilainen’s laboratory has been investigating a molecule, which now shows promise in targeting the...
Initial clinical data shows promising signals of the biological activity of CDNF in Parkinson's disease
Cerebral dopamine neurotrophic factor CDNF is being tested in phase one and two clinical trials in Finland and Sweden.